Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of coagulation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of coagulation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| VEGFA | vascular endothelial growth factor A | 0.998 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.995 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.994 | Human | |
| C1QA | complement component 1, q subcomponent, A chain | 0.993 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.971 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.967 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.950 | ||
| NRP1 | neuropilin 1 | 0.943 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.756 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.756 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.606 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.575 | Human | |
| SYK | spleen tyrosine kinase | 0.555 | ||
| S100A10 | S100 calcium binding protein A10 | 0.505 | ||
| PLAU | plasminogen activator, urokinase | 0.498 | Human Mouse | |
| PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.450 | ||
| PLG | plasminogen | 0.431 | ||
| PLAT | plasminogen activator, tissue | 0.421 | Human | |
| FGA | fibrinogen alpha chain | 0.400 | ||
| EGFR | epidermal growth factor receptor | 0.380 | ||
| PGF | placental growth factor | 0.290 | Human | |
| PDGFC | platelet derived growth factor C | 0.277 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.276 | ||
| APOC1 | apolipoprotein C-I | 0.261 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.249 | ||
| KNG1 | kininogen 1 | 0.216 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.195 | Human | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.181 | ||
| HP | haptoglobin | 0.176 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.108 | ||
| C1S | complement component 1, s subcomponent | 0.104 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.101 | ||
| FN1 | fibronectin 1 | 0.100 | ||
| ALB | albumin | 0.099 | ||
| CDCP1 | CUB domain containing protein 1 | 0.098 | ||
| ACTB | actin, beta | 0.093 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.086 | ||
| F11 | coagulation factor XI | 0.078 | ||
| LAT | linker for activation of T cells | 0.074 | ||
| SPINT1 | serine peptidase inhibitor, Kunitz type 1 | 0.071 | ||
| APOA2 | apolipoprotein A-II | 0.069 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.068 | ||
| C1R | complement component 1, r subcomponent | 0.064 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.064 | ||
| APOC3 | apolipoprotein C-III | 0.063 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.062 | ||
| AXL | AXL receptor tyrosine kinase | 0.062 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.061 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.061 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.058 | ||
| KITLG | KIT ligand | 0.055 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.055 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.049 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.048 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.046 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.042 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.041 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.041 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.038 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.038 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.037 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.035 | ||
| C8A | complement component 8, alpha polypeptide | 0.035 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.032 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.032 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.031 | ||
| LPA | lipoprotein, Lp(a) | 0.031 | Human | |
| HRG | histidine-rich glycoprotein | 0.030 | Mouse | |
| C8B | complement component 8, beta polypeptide | 0.029 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.029 | ||
| ARRDC3 | arrestin domain containing 3 | 0.029 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.029 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.029 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.029 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.028 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.027 | ||
| LDLR | low density lipoprotein receptor | 0.027 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.026 | ||
| ANXA1 | annexin A1 | 0.025 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.025 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.024 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.024 | ||
| STAB1 | stabilin 1 | 0.024 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.023 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.023 | ||
| VTN | vitronectin | 0.023 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.022 | Human | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.022 | ||
| C6 | complement component 6 | 0.021 | ||
| DCN | decorin | 0.021 | ||
| PLTP | phospholipid transfer protein | 0.020 | ||
| ORM1 | orosomucoid 1 | 0.018 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.018 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.018 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.018 | ||
| F10 | coagulation factor X | 0.017 | Human | |
| CYBA | cytochrome b-245, alpha polypeptide | 0.017 | ||
| MARCO | macrophage receptor with collagenous structure | 0.017 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.017 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.017 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.016 | ||
| VEGFC | vascular endothelial growth factor C | 0.016 | Human | |
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.016 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.016 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.015 | ||
| S100A11 | S100 calcium binding protein A11 | 0.015 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.015 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.015 | ||
| CRP | C-reactive protein, pentraxin-related | 0.015 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.015 | ||
| PTH1R | parathyroid hormone 1 receptor | 0.015 | ||
| VWF | von Willebrand factor | 0.014 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.014 | ||
| PRKCB | protein kinase C, beta | 0.014 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.014 | ||
| F9 | coagulation factor IX | 0.013 | Human | |
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.013 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.013 | ||
| TRIM9 | tripartite motif containing 9 | 0.013 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.013 | ||
| STC1 | stanniocalcin 1 | 0.013 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.013 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.013 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.013 | ||
| AFM | afamin | 0.013 | ||
| C2 | complement component 2 | 0.012 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.012 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.012 | ||
| APCS | amyloid P component, serum | 0.012 | ||
| APOC4 | apolipoprotein C-IV | 0.012 | ||
| MRVI1 | murine retrovirus integration site 1 homolog | 0.012 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.012 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.012 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.012 | ||
| MRC1 | mannose receptor, C type 1 | 0.012 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.012 | ||
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.012 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.012 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.012 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.012 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.012 | ||
| CFHR2 | complement factor H-related 2 | 0.012 | ||
| APOF | apolipoprotein F | 0.011 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.011 | ||
| MYO1D | myosin ID | 0.011 | ||
| PTEN | phosphatase and tensin homolog | 0.011 | ||
| ITGB5 | integrin, beta 5 | 0.011 | ||
| SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.011 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.011 | ||
| MSN | moesin | 0.011 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.011 | ||
| HPN | hepsin | 0.011 | ||
| C4BPB | complement component 4 binding protein, beta | 0.011 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.011 | ||
| SAA4 | serum amyloid A4, constitutive | 0.011 | ||
| TUBB6 | tubulin, beta 6 | 0.011 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.011 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.011 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.010 | Human | |
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.010 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.010 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.010 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.010 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.010 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.010 | Human | |
| FAM83C | family with sequence similarity 83, member C | 0.010 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.010 | ||
| NNMT | nicotinamide N-methyltransferase | 0.010 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.010 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.010 |